Body composition in premanifest Huntington’s disease reveals lower bone density compared to controls.
2011

Lower Bone Density in Premanifest Huntington's Disease

Sample size: 50 publication Evidence: moderate

Author Information

Author(s): Anna O. G. Goodman, Roger A. Barker

Primary Institution: University of Cambridge

Hypothesis

Does premanifest Huntington's disease lead to lower bone density compared to controls?

Conclusion

Premanifest individuals with Huntington's disease have significantly lower bone density compared to control subjects.

Supporting Evidence

  • Premanifest individuals showed significantly lower bone mineral density z-scores compared to controls.
  • The difference in bone density was not related to testosterone, cortisol, leptin, or Vitamin D levels.
  • The study suggests early gene-related changes in bone density may serve as potential biomarkers for Huntington's disease.

Takeaway

People who might get Huntington's disease have weaker bones than those who don't have the disease, even before they show any symptoms.

Methodology

Body composition was measured using DEXA scans in 25 premanifest Huntington's disease individuals and 25 matched controls.

Limitations

The control group may not represent the general population, and activity levels were not measured.

Participant Demographics

25 premanifest HD individuals and 25 age, sex, and ethnicity matched controls.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/currents.RRN1214

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication